(Q39487924)

12 September 2017

title

Anaplastic lymphoma kinase status in rhabdomyosarcomas (English)

1 reference

12 September 2017

1 reference

9

Hitoshi Tsuda

1 reference

12 September 2017

2

Tatsuhiro Shibata

1 reference

12 September 2017

Akihiko Yoshida

1

1 reference

12 September 2017

Susumu Wakai

3

1 reference

12 September 2017

Tetsuo Ushiku

4

1 reference

12 September 2017

Koji Tsuta

5

1 reference

12 September 2017

Masashi Fukayama

6

1 reference

12 September 2017

Atsushi Makimoto

7

1 reference

12 September 2017

Koh Furuta

8

1 reference

12 September 2017

publication date

11 January 2013

1 reference

12 September 2017

1 reference

12 September 2017

volume

26

1 reference

12 September 2017

issue

6

1 reference

12 September 2017

page(s)

772-781

1 reference

Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

ALK rearrangement in sickle cell trait-associated renal medullary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Oncogenic mutations of ALK kinase in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Crizotinib in anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: a study of 135 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

ALK protein expression in rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Comprehensive histologic analysis of ALK-rearranged lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

An immunohistochemical algorithm to facilitate diagnosis and subtyping of rhabdomyosarcoma: the Children's Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Expression of the ALK tyrosine kinase gene in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Anaplastic lymphoma kinase (ALK) inhibitor response in neuroblastoma is highly correlated with ALK mutation status, ALK mRNA and protein levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

7 January 2021

Sclerosing, pseudovascular rhabdomyosarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

7 January 2021

Relationship of DNA ploidy to histology and prognosis in rhabdomyosarcoma. Comparison of flow cytometry and image analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

7 January 2021

Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2012.222

7 January 2021

10.1038/MODPATHOL.2012.222

Identifiers

DOI

1 reference

12 September 2017

1 reference